22:41:18 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



E:CYBN - CYBIN INC. - http://www.cybin.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYBN - E  9.00.45·0.5012.50.47273.91153090.465  0.475  0.460.98  0.3016:16:23May 1415 min RT 2¢
NEO exchange - E9.00.45·0.5012.50.47197.9851520.465  0.475  0.460.98  0.3016:16:2315 min
Omega - O 0.4717.07290.47  0.47  0.46515:59:4015 min
Chi-X - X 0.465-0.005-1.15.5260.47  0.47  0.46514:37:2115 min
CX2 - H 0.4710.54210.465  0.47  0.4615:59:3315 min
CXD - D 0.465-0.005-1.14.71230.465  0.465  0.462515:59:3915 min
TriAct - M 0.475+0.0051.138.31578    15 min

Recent Trades - Last 10 of 309
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:16:23E0.47 0301 NEO Buy301 NEO BuyZ
15:59:54D0.47 951 Anonymous2 RBCE
15:59:41D0.47 4061 Anonymous14 Virtu ITGE
15:59:40O0.47 5001 Anonymous1 AnonymousK
15:59:39D0.465-0.0055001 Anonymous1 AnonymousK
15:59:39M0.465-0.0055001 Anonymous1 Anonymous
15:59:39E0.47 5,0001 Anonymous88 CredentialK
15:59:35E0.47 5001 Anonymous88 CredentialK
15:59:33O0.47 50080 National Bank1 AnonymousK
15:59:33H0.47 50080 National Bank1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-06 14:09C:CYBN0.485News ReleaseCybin reviews recent CYB003 activities
2024-04-18 13:00C:CYBN0.51News ReleaseCybin publishes CYB210010 research manuscript
2024-04-16 12:27C:CYBN0.51News ReleaseCybin receives depressive disorder therapy patent
2024-04-08 07:12C:CYBN0.55In the NewsGlobe says MindMed, Cybin get nod from U.S. FDA
2024-03-19 12:42C:CYBN0.61News ReleaseCybin closes $150-million (U.S.) private placement
2024-03-15 09:12C:CYBN0.61News ReleaseCybin begins phase 2 CYB004 study for GAD treatment
2024-03-14 11:30C:CYBN0.58News ReleaseCybin talks CYB003 phase 2 FDA meeting, phase 3 design
2024-03-13 09:16C:CYBN0.58News ReleaseCybin arranges $150-million (U.S.) private placement
2024-03-13 08:59C:CYBN0.57News ReleaseCybin's CYB003 receives FDA breakthrough designation
2024-03-12 23:17C:CYBN0.58News ReleaseCybin to host call March 13 for CYB003 update
2024-02-14 12:40C:CYBN0.475News ReleaseCybin has cash of $39-million at Dec. 31
2024-02-14 07:40C:CYBN0.475SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-14 07:34C:CYBN0.475SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-07 11:55C:CYBN0.395News ReleaseCybin receives two patents in Japan for DMT program
2024-01-23 09:05C:CYBN0.485News ReleaseCybin receives FDA OK to begin phase 2a CYB004 study
2024-01-08 11:46C:CYBN0.54News ReleaseCybin says CYB004, SPL028 well tolerated in phase 1
2024-01-04 10:54C:CYBN0.52News ReleaseCybin outlines phase 2 CYB003 results in MDD
2023-12-06 10:41C:CYBN0.57News ReleaseCybin receives U.S. patent for CYB003 program
2023-11-30 10:34C:CYBN0.64News ReleaseCybin boasts about CYB003 phase 2 safety, efficacy data
2023-11-16 12:46C:CYBN0.60News ReleaseCybin to release phase 2 CYB003 data Nov. 30